Several factors should be taken into account for treatment selection, including patient characteristics (age, comorbidity, symptoms, need for rapid tumor size reduction, family/caregiver support, compliance with oral medication) and tumor characteristics (site and number of metastases, BRAF status, PD-L1 expression). Here, BRAF is linked to neoplasm.